Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen S Kraft

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus DiseaseColleen S Kraft
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 22, 2011
Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosisJeannette Guarner, Colleen S Kraft
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Fecal Microbiota Transplantation: Tales of CautionSahil Khanna, Colleen S Kraft
Future Microbiology|April 13, 2021
The interplay of SARS-CoV-2 and <i>Clostridioides difficile</i> infectionSahil Khanna, Colleen S Kraft
Journal of Clinical Microbiology|September 1, 2021
Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2Mary Elizabeth Sexton, Colleen S Kraft
The Journal of Infectious Diseases|June 8, 2026
When Lassa Fever Travels: Lessons from a Nosocomial Outbreak in GuineaColleen S Kraft, Jill S Morgan
Journal of Oncology Practice|January 14, 2017
Diagnostic and Therapeutic Considerations for Oncology Patients With Clostridium difficile InfectionMichael H Woodworth, Colleen S Kraft
The American Journal of Gastroenterology|December 4, 2014
Diverticulitis after fecal microbiota transplant for C. difficile infectionAmar Mandalia, Colleen S Kraft, Tanvi Dhere
Clinical Chemistry|December 19, 2025
Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient MonitoringGrace Drew, Colleen S Kraft, Nirja Mehta
Southern Medical Journal|January 13, 2015
Use of standard donors in fecal microbiotal transplantsXiao Jing Wang, Colleen S Kraft, Tanvi Dhere
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus DiseaseColleen S Kraft
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 22, 2011
Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosisJeannette Guarner, Colleen S Kraft
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Fecal Microbiota Transplantation: Tales of CautionSahil Khanna, Colleen S Kraft
Future Microbiology|April 13, 2021
The interplay of SARS-CoV-2 and <i>Clostridioides difficile</i> infectionSahil Khanna, Colleen S Kraft
Journal of Clinical Microbiology|September 1, 2021
Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2Mary Elizabeth Sexton, Colleen S Kraft
The Journal of Infectious Diseases|June 8, 2026
When Lassa Fever Travels: Lessons from a Nosocomial Outbreak in GuineaColleen S Kraft, Jill S Morgan
Journal of Oncology Practice|January 14, 2017
Diagnostic and Therapeutic Considerations for Oncology Patients With Clostridium difficile InfectionMichael H Woodworth, Colleen S Kraft
The American Journal of Gastroenterology|December 4, 2014
Diverticulitis after fecal microbiota transplant for C. difficile infectionAmar Mandalia, Colleen S Kraft, Tanvi Dhere
Clinical Chemistry|December 19, 2025
Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient MonitoringGrace Drew, Colleen S Kraft, Nirja Mehta
Southern Medical Journal|January 13, 2015
Use of standard donors in fecal microbiotal transplantsXiao Jing Wang, Colleen S Kraft, Tanvi Dhere
Pageof 21